Subclinical Cerebrovascular Disease: Epidemiology and Treatment.
Subclinical Cerebrovascular Disease: Epidemiology and Treatment.
复制标题
DOI:
10.1007/s11883-019-0799-1
复制
发表时间:
2019-07-27
影响因子:
5.8
通讯作者:
Chung L
中科院分区:
文献类型:
--
作者:
de Havenon A;Meyer C;McNally JS;Alexander M;Chung L
Subclinical cerebrovascular disease (sCVD) is highly prevalent in older adults. The main neuroimaging findings of sCVD include white matter hyperintensities and silent brain infarcts on T2-weighted MRI and cerebral microbleeds on gradient echo or susceptibility weighted MRI. In this paper, we will review the epidemiology of sCVD, the current evidence for best medical management, and future directions for sCVD research. Numerous epidemiologic studies show that sCVD, in particular WMH, is an important risk factor for the development of dementia, stroke, worse outcomes after stroke, gait instability, late-life depression, and death. Effective treatment of sCVD could have major consequences for the brain health of a substantial portion of older Americans. Despite the link between sCVD and many vascular risk factors, such as hypertension or hyperlipidemia, the optimal medical treatment of sCVD remains uncertain. Given the clinical equipoise about the risk versus benefit of aggressive medical management for sCVD, clinical trials to examine pragmatic, evidence-based approaches to management of sCVD are needed. Such a trial could provide much needed guidance on how to manage a common clinical scenario facing internists and neurologists in practice.
登录
查看更多内容
DOI:
10.1161/01.atv.0000258947.17570.38
发表时间:
2007-04-01
影响因子:
8.7
作者:
Aono, Yoko;Ohkubo, Takayoshi;Imai, Yutaka
通讯作者:
Imai, Yutaka
影响因子:
9.9
作者:
de Havenon, Adam;Majersik, Jennifer J.;Rost, Natalia S.
通讯作者:
Rost, Natalia S.
影响因子:
8.3
作者:
Gregoire, Simone M.;Brown, Martin M.;Werring, David J.
通讯作者:
Werring, David J.
影响因子:
9.9
作者:
Charidimou, Andreas;Shoamanesh, Ashkan;Werring, David J.
通讯作者:
Werring, David J.
影响因子:
8.3
作者:
Baradaran, Hediyeh;Gialdini, Gino;Gupta, Ajay
通讯作者:
Gupta, Ajay